These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-000441-38 A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy 2007-07-11 bad-data
Listed as ongoing, but also has a completion date 2004-002181-38 WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) 2011-07-19 bad-data
Exempt 2004-004314-16 Ensayo multicéntrico de tratamiento de la hipotiroxinemia transitoria en los niños <= 1000 gr de peso al nacimiento o <= 28 semanas de gestación y seguimiento del desarrollo psicomotor hasta los 5 año... not-yet-due
Listed as ongoing, but also has a completion date 2005-001490-95 A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD... 2011-02-28 bad-data
Completed, but no date 2005-003242-34 Secondary Prevention of Small Subcortical Strokes bad-data
Not reported 2006-003554-15 The histone deacetylase inhibitor (HDAC) valproic acid as second line treatment for hormone refractory metastatic prostate cancer. A phase II. study. 2009-02-28 due-trials
Ongoing 2007-000618-35 PHASE II TRIAL OF PACLITAXEL, GEMCITABINE AND CISPLATIN IN PATIENTS WITH RELAPSING GERM CELL CANCER AFTER FIRST LINE CHEMOTHERAPY not-yet-due
Ongoing 2007-003612-53 Multicenter Uveitis Steroid Treatment Trial not-yet-due
Not reported 2008-001210-25 Open Randomized Multi-Center Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation. 2014-08-21 due-trials
Ongoing 2009-013647-10 Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland not-yet-due
Trial is outside EEC, and reported results 2009-015884-15 A Phase I/II, Multicenter, Open-Label, Non comparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the bad-data
Not reported 2011-001078-25 Long-term Follow-up of Patients Who Participated in the Multicenter Uveitis Steroid Treatment Trial (MUST Trial Follow-up Study). 2016-12-31 due-trials
Completed, but no date 2011-001502-10 Phase II study of Everolimus in refractory testicular germ cell cancer. bad-data
Trial is outside EEC 2011-001680-44 A Phase I/II, Open-Label Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Rilpivirine in Antiretroviral Naive HIV-1 Infected Children, < 12 Years of Age bad-data
Trial is partly outside EEC 2011-004257-29 A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High Risk Melanoma bad-data
Trial is outside EEC 2011-004934-32 A phase I/II trial of vandetanib in children and adolescents with hereditary medullary thyroid cancer. bad-data
Trial is outside EEC, and reported results 2012-000690-23 A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors bad-data
Trial is outside EEC, and reported results 2012-001141-41 A PHASE I STUDY OF IPILIMUMAB (ANTI-CTLA-4) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH TREATMENT REFRACTORY CANCER bad-data
Trial is outside EEC, and reported results 2012-001306-20 A PHASE I STUDY OF PAZOPANIB AS A SINGLE AGENT FOR CHILDREN WITH RELAPSED OR REFRACTORY SOLID TUMORS, INCLUDING CNS TUMORS bad-data
Trial is outside EEC 2012-002630-36 A PHASE I/II, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF ETRAVIRINE (ETR) IN ANTIRETROVIRAL (ARV) TREATMENT-EXPERIENCED HIV-1 INFECTED INFANTS A... bad-data
Exempt 2012-004579-37 Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI not-yet-due
Reported results 2012-005486-13 A Phase II Randomized Study to Compare Anti-VEGF Agents in the Treatment of Diabetic Macular Edema (CADME) 2015-02-04 due-trials
Trial is outside EEC, and reported results 2013-000300-42 A long-term outcome study with the IL-1 receptor antagonist Anakinra/Kineret® in patients with Neonatal onset multisystem inflammatory disease (Nomid/Cinca syndrome) bad-data
Ongoing 2013-003049-41 A Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children not-yet-due
Ongoing 2013-003481-14 Study of allopurinol to prevent GFR loss in type 1 diabetes not-yet-due
Completed, but no date Terminated 2013-004526-28 A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Ha... bad-data
Trial is outside EEC, and reported results 2014-005134-64 Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, ATAZANAVIR, ATV, REYATAZ™) in Combination Regimens in Antiretroviral Therapy (ART)-Naïve and Experien... bad-data
Trial is outside EEC 2014-005674-11 A PHASE 1/2 STUDY OF NIVOLUMAB (IND# 124729) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RECURRENT OR REFRACTORY SOLID TUMORS AS A SINGLE AGENT AND IN COMBINATION WITH IPILIMUMAB bad-data
Ongoing 2015-000602-18 A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus Host-Disease not-yet-due
Ongoing 2015-002283-16 Phase II randomized, placebo-controlled, double blind clinical trial of valsartan for attenuating disease evolution in early sarcomeric HCM not-yet-due
Trial is outside EEC 2016-000847-16 A Phase 1/2 Study of the Mitogen Activated Protein Kinase Kinase(MEK) 1 Inhibitor Selumetinib (AZD6244, ARRY-142886, Hydrogen Sulfate) in Children With Neurofibromatosis Type 1 (NF1) and Inoperable Pl... bad-data
Ongoing 2016-002498-36 Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception not-yet-due
Trial is outside EEC, and reported results 2016-003248-34 A PHASE I TRIAL TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF RALTEGRAVIR IN HIV-1-EXPOSED NEONATES AT HIGH RISK OF ACQUIRING HIV-1 INFECTION bad-data
Ongoing 2017-000946-24 Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration not-yet-due
Ongoing 2017-001179-21 A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions not-yet-due
Trial is outside EEC 2017-001518-27 Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-infected Children and Adolescents bad-data
Trial is outside EEC 2017-004364-35 Eltrombopag added to standard immunosuppression in treatment-naïve severe aplastic anemia. bad-data
Trial is outside EEC 2018-004591-35 A PHASE 1 STUDY OF XL184 (CABOZANTINIB, IND# 116059) IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS, INCLUDING CNS TUMORS bad-data